Ulcerative colitis (UC) is a chronic, non-specific inflammatory disease of the intestinal tract, the etiology of which remains uncertain. Ulcerative colitis associated colorectal cancer (UC-CRC) stands as one of the most severe complications for UC patients, presenting as a significant cause of mortality. Due to its distinctive clinical features, the indications of surgery, optimal timing, surgical approach, and perioperative management differ from those of sporadic colorectal cancer. This article aims to provide a comprehensive review of the current status of surgical treatments for UC-CRC and perioperative management, serving as a valuable reference for clinical practice.

1.Le Berre C, Ricciuto A, Peyrin-Biroulet L, et al. Evolving short- and long-term goals of management of inflammatory bowel diseases: getting it right, making it last[J]. Gastroenterology, 2022, 162(5): 1424-1438. DOI: 10.1053/j.gastro.2021.09.076.

2.Singh S, Allegretti JR, Siddique SM, et al. AGA Technical review on the management of moderate to severe ulcerative colitis[J]. Gastroenterology, 2020, 158(5): 1465-1496.e17. DOI: 10.1053/j.gastro.2020.01.007.

3.Pratt M, Forbes JD, Knox NC, et al. Colorectal cancer screening in inflammatory bowel diseases-can characterization of gi microbiome signatures enhance neoplasia detection?[J]. Gastroenterology, 2022, 162(5): 1409-23.e1. DOI: 10.1053/j.gastro.2021.12.287.

4.Birch RJ, Burr N, Subramanian V, et al. Inflammatory bowel disease-associated colorectal cancer epidemiology and outcomes: an English population-based study[J]. Am J Gastroenterol, 2022, 117(11): 1858-1870. DOI: 10.14309/ajg.0000000000001941.

5.Narula N, Hu A, Nguyen GC, et al. Periodic colonoscopies are associated with improved survival and prognosis of colorectal cancer in ulcerative colitis[J]. Dig Dis Sci, 2022, 67(5): 1850-1857. DOI: 10.1007/s10620-021-07151-7.

6.中华医学会外科学分会结直肠外科学组, 中国医师协会肛肠医师分会炎症性肠病专业委员会. 中国溃疡性结肠炎外科治疗指南[J]. 中华炎性肠病杂志, 2022, 6(1): 7-16. [Chinese Society of Colorectal Surgery, Inflammatory Bowel Disease Committee, Anorectal Doctor Branch, Chinese Medical Doctor Association. Guidelines for surgical treatment of ulcerative colitis in China[J]. Chinese Journal of Inflammatory Bowel Diseases, 2022, 6(1): 7-16.] DOI: 10.3760/cma.j.cn101480-20211207-00100.

7.Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis[J]. Nat Rev Dis Primers, 2020, 6(1): 74. DOI: 10.1038/s41572-020-0205-x.

8.Baek SJ, Lee KY, Song KH, et al. Current status and trends in inflammatory bowel disease surgery in Korea: analysis of data in a nationwide registry[J]. Ann Coloproctol, 2018, 34(6): 299-305. DOI: 10.3393/ac.2018.07.21.

9.De Jong ME, Van Tilburg SB, Nissen LHC, et al. Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with inflammatory bowel disease: a nationwide cohort study[J]. J Crohns Colitis, 2019, 13(12): 1485-1491. DOI: 10.1093/ecco-jcc/jjz114.

10.Stewart MJ. Does Surveillance increase survival? benefits of periodic colonoscopy in patients with ulcerative colitis and colorectal cancer[J]. Dig Dis Sci, 2022, 67(5): 1704-1706. DOI: 10.1007/s10620-021-07174-0.

11.Cole EB, Shah Y, Mclean LP, et al. Frequency of surveillance and impact of surveillance colonoscopies in patients with ulcerative colitis who developed colorectal cancer[J]. Clin Colorectal Cancer, 2018, 17(2): e289-e292. DOI: 10.1016/j.clcc.2018.01.002.

12.Eder P, Łodyga M, gawron-kiszka M, et al. Guidelines for the management of ulcerative colitis. Recommendations of the polish society of gastroenterology and the polish national consultant in gastroenterology[J]. Prz Gastroenterol, 2023, 18(1): 1-42. DOI: 10.5114/pg.2023.125882.

13.Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management[J]. gastroenterology, 2022, 162(3): 715-730.e3. DOI: 10.1053/j.gastro.2021.10.035.

14.张琴, 万健, 吴开春, 等.溃疡性结肠炎癌变流行病学调查:一项全国多中心回顾性研究 [J]. 中华炎性肠病杂志, 2017, 1(3): 155-159. [Zhang Q, Wan J, Wu KC, et al. An epidemiological survey of ulcerative colitis-associated with colorectal cancer: a national multicenter retrospective study[J]. Chinese Journal of Inflammatory Bowel Diseases, 2017, 1(3): 155-159.] DOI: 10.3760/cma.j.issn.2096-367X.2017.03.009.

15.Kucharzik T, Ellul P, Greuter T, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease[J]. J Crohns Colitis. 2021, 15(6): 879-913. DOI: 10.1093/ecco-jcc/jjab052.

16.Chohno T, Uchino M, Sasaki H, et al. Associations between the prognostic nutritional index and morbidity/mortality during intestinal resection in patients with ulcerative colitis[J]. World J Surg, 2018, 42(7): 1949-1959. DOI: 10.1007/s00268-017-4411-y.

17.Fitzpatrick JA, Melton SL, Yao CK, et al. Dietary management of adults with IBD - the emerging role of dietary therapy[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(10): 652-669. DOI: 10.1038/s41575-022-00619-5.

18.Dua A, Corson M, Sauk JS, et al. Impact of malnutrition and nutrition support in hospitalised patients with inflammatory bowel disease[J]. Aliment Pharmacol Ther, 2023, 57(8): 897-906. DOI: 10.1111/apt.17389.

19.Jabłońska B, Mrowiec S. Nutritional status and its detection in patients with inflammatory bowel diseases[J]. Nutrients, 2023, 15(8): 1991. DOI: 10.3390/nu15081991.

20.黄钊鹏, 晁康, 林敏芝, 等. 肠内营养在炎症性肠病治疗中的应用现状[J]. 中华消化杂志, 2022, 42(4): 281-284. [Huang ZP, Chao K, Lin MZ, et al. Current status of enteral nutrition in the treatment of inflammatory bowel disease[J]. Chinese Journal of Digestion, 2022, 42(4): 281-284.] DOI: 10.3760/cma.j.cn311367-20210616-00338.

21.张允, 李惠玲, 童淑萍. 营养不良通用筛查工具和营养风险筛查2002在炎症性肠病住院患者中应用效果的比较[J]. 解放军护理杂志, 2015, 32(10): 29-32, 37. [Zhang Y, Li HL, Tong SP. Comparison of the application effect of malnutrition universal screening tool and nutritional risk screening 2002 in hospitalized patients with inflammatory bowel disease[J]. Military Nursing, 2015, 32(10): 29-32, 37.] DOI: 10.3969/j.issn.1008-9993.2015.10.011.

22.Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults[J]. Am J Gastroenterol, 2019, 114(3): 384-413. DOI: 10.14309/ajg.0000000000000152.

23.Takakura H, Horinaka M, Imai A, et al. Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells[J]. J Clin Biochem Nutr, 2022, 70(2): 93-102. DOI: 10.3164/jcbn.21-74.

24.Federica S, Francesco C, Sabrina D, et al. Inflammatory bowel diseases: an updated overview on the heat shock protein involvement[J]. Int J Mol Sci, 2023, 24(15): 12129. DOI: 10.3390/ijms241512129.

25.Zhu Z, ,Mei Z, Guo Y, et al. Reduced risk of inflammatory bowel disease-associated colorectal neoplasia with use of thiopurines: a systematic review and Meta-analysis[J]. J Crohns Colitis, 2018, 12(5): 546-558.  DOI: 10.1093/ecco-jcc/jjy006.

26.Yang Z, Wu Q, Wang F, et al. Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery[J]. Aliment Pharmacol Ther, 2012, 36(10): 922-8. DOI: 10.1111/apt.12060.

27.Wang DY, Ohnuma S, Suzuki H, et al. Infliximab inhibits colitis associated cancer in model mice by downregulating genes associated with mast cells and decreasing their accumulation[J]. Curr Issues Mol Biol. 2023, 45(4): 2895-2907. DOI: 10.3390/cimb45040189.

28.Charkaoui M, Hajage D, Tubach F, et al. Impact of anti-tumour necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide french cohort study[J]. J Crohns Colitis, 2022, 16(6): 893-899. DOI: 10.1093/ecco-jcc/jjab184.

29.Kulaylat AS, kulaylat AN, schaefer EW, et al. Association of preoperative anti-tumor necrosis factor therapy with adverse postoperative outcomes in patients undergoing abdominal surgery for ulcerative colitis[J]. JAMA Surg, 2017, 152(8): e171538. DOI: 10.1001/jamasurg.2017.1538.

30.Quaresma AB, Baraúna FDSB, Teixeira FV, et al. Exploring the relationship between biologics and postoperative surgical morbidity in ulcerative colitis: a review[J]. J Clin Med. 2021, 10(4):710. DOI: 10.3390/jcm10040710.

31.Shen B, Blake A, Lasch K, et al. Vedolizumab use in patients with inflammatory bowel diseases undergoing surgery: clinical trials and post-marketing experience[J]. Gastroenterol Rep (Oxf), 2019, 7(5): 322-330. DOI: 10.1093/gastro/goz034.

32.Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis[J]. Br Med J, 1978, 2(6130): 85-88. DOI: 10.1136/bmj.2.6130.85.

33.De Buck van Overstraeten A, Brar MS, Khorasani S, et al. Ileorectal anastomosis versus IPAA for the surgical treatment of ulcerative colitis: a markov decision analysis[J]. Dis Colon Rectum, 2020, 63(9): 1276-1284.  DOI: 10.1097/DCR.0000000000001686.

34.Risto A, Abdalla M, Myrelid P. Staging pouch surgery in ulcerative colitis in the biological era[J]. Clin Colon Rectal Surg, 2022, 35(1): 58-65.  DOI: 10.1055/s-0041-1740039.

35.Mège D, Figueiredo MN, Manceau G, et al. Three-stage laparoscopic ileal pouch-anal anastomosis is the best approach for high-risk patients with inflammatory bowel disease: an analysis of 185 consecutive patients[J]. J Crohns Colitis, 2016, 10(8): 898-904. DOI: 10.1093/ecco-jcc/jjw040.

36.Kotze PG, Heuthorst L, Lightner AL, et al. New insights on the surgical management of ulcerative colitis in the 21st century[J]. Lancet Gastroenterol Hepatol, 2022, 7(7): 679-688. DOI: 10.1016/S2468-1253(22)00001-2.

37.Shen B, Kochhar GS, Kariv R, et al. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the international ileal pouch consortium[J]. Lancet Gastroenterol Hepatol, 2021, 6(10): 826-849. DOI: 10.1016/S2468-1253(21)00101-1.

38.İsmail E, Açar H, Arslan MN, et al. Comparison of mesenteric lengthening techniques in IPAA: an anatomic and angiographic study on fresh cadavers[J]. Dis Colon Rectum, 2018, 61(8): 979-987. DOI: 10.1097/DCR.0000000000001133.

39.Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients[J]. Ann Surg, 2013, 257(4): 679-685. DOI: 10.1097/SLA.0b013e31827d99a2.

40.练磊, 熊家庆, 黄群生, 等. 溃疡性结肠炎术后常见并发症及处理 [J]. 中华炎性肠病杂志, 2018, 2(4): 276-278. [Lian L, Xiong JQ, Huang QS, et al. Common postoperative complications and management of ulcerative colitis[J]. Chinese Journal of Inflammatory Bowel Diseases, 2018, 2(4): 276-278.] DOI: 10.3760/cma.j.issn.2096-367X.2018.04.010.

41.Nguyen N, Zhang B, Holubar SD, et al. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis[J]. Cochrane Database Syst Rev, 2019, 11(11): Cd001176. DOI: 10.1002/14651858.CD001176.pub5.

42.李毅, 龚剑峰, 朱维铭. 围手术期外科之家理念及其在炎症性肠病管理中应用[J]. 中国实用外科杂志, 2020, 40(5): 511-514. [Li Y, Gong JF, Zhu WM. Construction of perioperative surgical home model for inflammatory bowel diseases[J]. Chinese Journal of Practical Surgery, 2020, 40(5): 511-514.] DOI: 10.19538/j.cjps.issn1005-2208.2020.05.07.

43.Meima-van Praag EM, Reijntjes MA, Hompes R, et al. Classification of surgical causes of and approaches to the chronically failing ileoanal pouch[J]. Tech Coloproctol, 2023, 27(4): 271-279. DOI: 10.1007/s10151-022-02688-9.

44.Lee GC, Bhama AR. Minimally invasive and robotic surgery for ulcerative colitis[J]. Clin Colon Rectal Surg, 2022, 35(6): 463-8. DOI: 10.1055/s-0042-1758137.

45.Morowitz DA, Kirsner JB. Ileostomy in ulcerative colitis. A questionnaire study of 1803 patients[J]. Am J Surg, 1981, 141(3): 370-375. DOI: 10.1016/0002-9610(81)90199-9.

46.Abdalla M, Norblad R, Olsson M, et al. Anorectal function after ileo-rectal anastomosis is better than pelvic pouch in selected ulcerative colitis patients[J]. Dig Dis Sci, 2020, 65(1): 250-259. DOI: 10.1007/s10620-019-05757-6.

47.Abdalla M, Landerholm K, andersson P, et al. Risk of rectal cancer after colectomy for patients with ulcerative Colitis: A National Cohort Study[J]. Clin Gastroenterol Hepatol, 2017, 15(7): 1055-1060.e2. DOI: 10.1016/j.cgh.2016.11.036.